Targeted Next Generation Sequencing Identifies Variants of Standard Biomarkers and Potentially Actionable Alterations in a Majority of Advanced Breast Cancer Patients

被引：0

作者：

Estrada, Monica ^{[1
]}

Giltnane, Jennifer ^{[1
]}

Balko, Justin ^{[1
]}

Mayer, Ingrid ^{[1
]}

Abramson, Vandana ^{[1
]}

Rexer, Brent ^{[1
]}

Means, Julie ^{[1
]}

Sanders, Melinda ^{[1
]}

机构：

[1] Vanderbilt Univ, Med Ctr, Nashville, TN USA

来源：

MODERN PATHOLOGY | 2015年 / 28卷

关键词：

D O I：

暂无

中图分类号：

R36 [病理学];

学科分类号：

100104 ;

摘要：

163

引用

页码：44A / 44A

页数：1

共 50 条

[1] Targeted Next Generation Sequencing Identifies Variants of Standard Biomarkers and Potentially Actionable Alterations in a Majority of Advanced Breast Cancer Patients
Estrada, Monica
Giltnane, Jennifer
Balko, Justin
Mayer, Ingrid
Abramson, Vandana
Rexer, Brent
Means, Julie
Sanders, Melinda
LABORATORY INVESTIGATION, 2015, 95 : 44A - 44A
[2] Targeted next generation sequencing of advanced breast cancers identifies potentially actionable alterations and variants of standard biomarkers in the majority of patients
Estrada, M. V.
Warner, J.
Rioth, M.
Balko, J. M.
Rexer, B.
Sanders, M. E.
CANCER RESEARCH, 2016, 76
[3] Clinical targeted next-generation sequencing to identify potentially actionable alterations in the majority of Asian cancer patients.
Poon, Song Ling
Lu, Yen-Jung
Jhou, Ren-Shiang
Yang, Yi-Ting
Yu, Pei-Ning
Liu, Yen-Ting
Hsieh, Yi-Lin
Nairismagi, Maarja-Liisa
Chen, Shu-Jen
Tan, Kien Thiam
JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
[4] Next Generation Sequencing Reveals Potentially Actionable Alterations in the Majority of Patients with Lymphoid Malignancies
Goodman, Aaron M.
Choi, Michael Y.
Wieduwilt, Matthew J.
Mulroney, Carolyn M.
Costello, Caitlin L.
Kurzrock, Razelle
BLOOD, 2016, 128 (22)
[5] Next-Generation Sequencing Reveals Potentially Actionable Alterations in the Majority of Patients With Lymphoid Malignancies
Goodman, Aaron M.
Choi, Michael
Wieduwilt, Matthew
Mulroney, Carolyn
Costello, Caitlin
Frampton, Garrett
Miller, Vincent
Kurzrock, Razelle
JCO PRECISION ONCOLOGY, 2017, 1 : 1 - 13
[6] Next generation sequencing to reveal potentially actionable alterations in the majority of patients with hematologic malignancies.
Galanina, Natalie
Goodman, Aaron
Tran, Lisa
Bejar, Rafael
Choi, Michael Y.
Kurzrock, Razelle
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
[7] Targeted next generation sequencing identifies somatic variants in Egyptian breast cancer patients
Nassar, Auhood
Abouelhoda, Mohamed
Bahnassy, Abeer
Youssef, Amira Salah El-Din
Lotfy, Mai M.
Ahmed, Ola S.
Ismail, Hoda
Zekri, Abdel-Rahman N.
CANCER RESEARCH, 2020, 80 (16)
[8] Targeted Massively Parallel Sequencing of Breast Cancer Metastases Identifies Potentially Actionable Molecular Alterations
Muller, K. E.
Marotti, J. D.
Chamberlin, M. D.
Tsongalis, G. J.
Tafe, L. J.
JOURNAL OF MOLECULAR DIAGNOSTICS, 2015, 17 (06): : 835 - 835
[9] Targeted next generation sequencing identifies clinically actionable mutations in patients with melanoma
Jeck, William R.
Parker, Joel
Carson, Craig C.
Shields, Janiel M.
Sambade, Maria J.
Peters, Eldon C.
Burd, Christin E.
Thomas, Nancy E.
Chiang, Derek Y.
Liu, Wenjin
Eberhard, David A.
Ollila, David
Grilley-Olson, Juneko
Moschos, Stergios
Hayes, D. Neil
Sharpless, Norman E.
PIGMENT CELL & MELANOMA RESEARCH, 2014, 27 (04) : 653 - 663
[10] Spectrum of Actionable Variants Identified by Clinical Targeted Next-Generation Sequencing in Cancer
Al-Kateb, H.
Hageman, I.
Cottrell, C. E.
Lockwood, C.
Nguyen, T.
Duncavage, E. J.
Spencer, D.
Bredemeyer, A.
Cox, T.
Hussaini, M.
Head, R.
Shrivastava, S.
Nagarajan, R.
Seibert, K.
Kulkarni, S.
Pfeifer, J.
JOURNAL OF MOLECULAR DIAGNOSTICS, 2013, 15 (06): : 906 - 906

← 1 2 3 4 5 →